Levonorgestrel IUS (Mirena, BAY86-5028)
Sponsors
Bayer
Conditions
ContraceptionMenorrhagiaMenorrhagia, Dysmenorrhea
Phase 2
Phase 3
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
CompletedNCT00360490
Start: 2006-07-31End: 2008-06-30Updated: 2013-12-09
Mirena Extension Trial
CompletedNCT02985541
Start: 2016-12-22End: 2021-05-28Updated: 2022-04-28
Unknown Phase
Acceptability of Long-term Progestin-only Contraception in Europe
CompletedNCT00931827
Start: 2008-01-31End: 2011-11-30Updated: 2013-12-24
Mirena Post-marketing Surveillance in Japan
CompletedNCT01414140
Start: 2007-05-31End: 2012-10-31Updated: 2014-01-09
Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion
CompletedNCT01958684
Start: 2013-10-31End: 2014-10-31Updated: 2015-10-16
Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
CompletedNCT02475356
Start: 2015-08-04End: 2019-12-12Updated: 2021-01-28